精东传媒APP黄

University of Manchester scientists studying  invasive aspergillosis are both the world鈥檚 most cited and  the most prolific on the topic, according to an analysis published by Guangxi university in the journal Medicine.

F2G, a University of Manchester spinout company, is to partner a major Japanese pharmaceutical company in the commercialisation of a novel antifungal treatment it developed for invasive aspergillosis and other rare mould infections.